Intravenous and regional paclitaxel formulations

Area of Science:

• Oncology
• Pharmacology
• Biomedical Engineering

Background:

• Paclitaxel is a potent chemotherapeutic agent with demonstrated efficacy across various cancer types.
• Effective cancer treatment necessitates drug delivery systems that achieve high local concentrations at the tumor site.
• Such high concentrations are crucial for eradicating malignant cells and inhibiting tumor recurrence and metastasis.

Purpose of the Study:

• To review and discuss various paclitaxel formulations for cancer therapy.
• To explore systemic and intratumoral administration strategies for paclitaxel.
• To highlight the role of drug delivery systems in optimizing paclitaxel's anti-cancer effects.

Main Methods:

• Literature review of existing studies on paclitaxel formulations.
• Analysis of systemic administration approaches for paclitaxel.
• Evaluation of intratumoral delivery systems for paclitaxel.

Main Results:

• Paclitaxel formulations can be administered systemically or intratumorally.
• Delivery systems are key to achieving high, localized drug concentrations.
• Optimized delivery aims to maximize cytotoxicity to cancer cells while minimizing systemic toxicity.

Conclusions:

• Paclitaxel remains a vital chemotherapeutic agent for diverse cancers.
• Advanced drug delivery systems are critical for enhancing paclitaxel's therapeutic index.
• Targeted delivery strategies hold significant promise for improving patient outcomes by preventing tumor regrowth and metastasis.